{"id":568396,"date":"2026-09-18T02:00:00","date_gmt":"2026-09-18T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/uterus-myomatosus-and-heavy-menstrual-bleeding-oral-gnrh-antagonists\/"},"modified":"2026-09-23T17:27:54","modified_gmt":"2026-09-23T15:27:54","slug":"uterus-myomatosus-and-heavy-menstrual-bleeding-oral-gnrh-antagonists","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/uterus-myomatosus-and-heavy-menstrual-bleeding-oral-gnrh-antagonists\/","title":{"rendered":"Uterus myomatosus and heavy menstrual bleeding: oral GnRH antagonists"},"content":{"rendered":"\n

Uterine fibroids are the most common tumors of the female reproductive organs, but only about one-quarter of affected women develop symptoms that require treatment. The most common symptoms are heavy or prolonged menstrual bleeding, which can lead to iron deficiency and, consequently, fatigue and anemia. In addition, fibroid-related hypermenorrhea is often more painful than normal menstrual bleeding, and the pain lasts longer, which can significantly impair quality of life [6]. Until a few years ago, surgical procedures\u2014particularly hysterectomy\u2014were the most common treatment option; medication options were very limited [6]. Since February 2023, an alternative has been approved in Switzerland in the form of an oral fixed-dose combination of a GnRH receptor antagonist and low-dose hormonal add-back therapy, for which data spanning two years of treatment are now available.<\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Uterine fibroids are the most common tumors of the female reproductive organs, but only about one-quarter of affected women develop symptoms that require treatment. The most common symptoms are heavy……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":568398,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Two years of controlled data, two suppression strategies, and the risks associated with discontinuation","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11508,11400,11503,11380],"tags":[102364,77916,102362],"powerkit_post_featured":[],"class_list":["post-568396","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-education","category-gynecology","category-studies","category-surgery","tag-linzagolix","tag-myoma","tag-uterus-myomatosus","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-30 20:44:00","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":568372,"slug":"myome-uterin-et-saignements-menstruels-abondants-antagonistes-oraux-de-la-gnrh","post_title":"Myome ut\u00e9rin et saignements menstruels abondants : antagonistes oraux de la GnRH","href":"https:\/\/medizinonline.com\/fr\/myome-uterin-et-saignements-menstruels-abondants-antagonistes-oraux-de-la-gnrh\/"},"it_IT":{"locale":"it_IT","id":568378,"slug":"utero-miomatoso-e-menarca-abbondante-antagonisti-orali-del-gnrh","post_title":"Utero miomatoso e menarca abbondante: antagonisti orali del GnRH","href":"https:\/\/medizinonline.com\/it\/utero-miomatoso-e-menarca-abbondante-antagonisti-orali-del-gnrh\/"},"pt_PT":{"locale":"pt_PT","id":568384,"slug":"utero-miomatoso-e-hemorragia-menstrual-intensa-antagonistas-orais-da-gnrh","post_title":"\u00datero miomatoso e hemorragia menstrual intensa: antagonistas orais da GnRH","href":"https:\/\/medizinonline.com\/pt-pt\/utero-miomatoso-e-hemorragia-menstrual-intensa-antagonistas-orais-da-gnrh\/"},"es_ES":{"locale":"es_ES","id":568453,"slug":"utero-miomatoso-y-sangrado-menstrual-abundante-antagonistas-orales-de-la-gnrh","post_title":"\u00datero miomatoso y sangrado menstrual abundante: antagonistas orales de la GnRH","href":"https:\/\/medizinonline.com\/es\/utero-miomatoso-y-sangrado-menstrual-abundante-antagonistas-orales-de-la-gnrh\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/568396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=568396"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/568396\/revisions"}],"predecessor-version":[{"id":568400,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/568396\/revisions\/568400"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/568398"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=568396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=568396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=568396"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=568396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}